MEDITOPE-ENABLED T CELLS
Provided herein are compositions which exhibit novel therapeutic capabilities and allow to reduce the off-target effect of therapeutic antibodies. The compositions include recombinant proteins that if expressed by a T cell can efficiently recruit therapeutic antibodies to their site of action.
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
04.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are compositions which exhibit novel therapeutic capabilities and allow to reduce the off-target effect of therapeutic antibodies. The compositions include recombinant proteins that if expressed by a T cell can efficiently recruit therapeutic antibodies to their site of action. |
---|---|
Bibliography: | Application Number: EP20180896671 |